Congenital Heart Defects Lecture Review

Fundamentals and Classification of Congenital Heart Defects

• Definition: Congenital heart defects (CHD) are structural anomalies of the heart or great vessels that are present at birth.

• Epidemiology: Congenital heart disease accounts for the largest percentage of all birth defects.

• Scope of Nursing Knowledge: Care of pediatric patients with congenital heart defects requires an understanding of underlying pathophysiologic mechanisms, classifications, diagnostic evaluations, nursing processes for congestive heart failure (CHF), and therapeutic management across lifespan transitions.

Health History and Assessment Parameters

• History of Present Illness (HPI):

  • Exact onset of symptoms and patterns of progression.

  • Home treatments, therapies, and medications utilized.

  • Specific clinical indicators:

    • Orthopnea and dyspnea

    • Easy fatigability and fatigue during feedings

    • Growth delays and failure to thrive

    • Squatting behavior (compensatory mechanism for hypoxia)

    • Edema

    • Dizziness

    • Frequent bouts of pneumonia

    • Poor feeding, lethargy, and vomiting

    • Diaphoresis (especially during feeding)

    • Delays in motor development

    • Cyanosis

    • Tachypnea

• Past Health History:

  • Post-birth problems and associated congenital malformations.

  • History of frequent or recurrent infections.

  • Chromosomal or genetic abnormalities.

  • Prematurity.

  • Autoimmune disorders.

  • Maternal or pediatric use of medications, such as corticosteroids.

Hemodynamic Classifications of Congenital Heart Defects

• Left-to-Right Shunting Lesions (Increased Pulmonary Blood Flow):

  • Patent Ductus Arteriosus (PDA)

  • Atrial Septal Defect (ASD)

  • Ventricular Septal Defect (VSD)

• Decreased Pulmonary Blood Flow Lesions:

  • Tetralogy of Fallot (ToF)

  • Tricuspid Atresia

• Obstructive or Stenotic Lesions (Decreased Cardiac Outflow):

  • Coarctation of the Aorta (CoA)

  • Aortic Stenosis (AS)

  • Pulmonary Stenosis (PS)

• Mixed or Cyanotic Lesions (Variable/Increased Pulmonary Blood Flow):

  • Transposition of the Great Vessels (TGV) / Transposition of the Great Arteries (TGA)

  • Total Anomalous Pulmonary Venous Return (TAPVR)

  • Truncus Arteriosus

  • Hypoplastic Left Heart Syndrome (HLHS)

Increased Pulmonary Blood Flow Lesions (Septal Defects and PDA)

• Atrial Septal Defect (ASD):

  • Pathophysiology: An abnormal opening in the interatrial septum causing a left-to-right shunt.

  • Clinical Manifestations:

    • Symptom severity depends directly on the size of the defect and the volume of the left-to-right shunt.

    • Infants and young children are usually asymptomatic. Small to moderate ASDs may escape diagnosis until preschool years or later, often discovered incidentally following routine murmur detection.

    • Adults presenting with ASD typically have small-to-moderate defects, as larger lesions are identified earlier in life.

    • Symptomatic presentations include pulmonary arterial hypertension, atrial dysrhythmias, exercise intolerance, and congestive heart failure (CHF).

  • Auscultatory Findings:

    • First heart sound ($S_1$) may be split, reflecting forceful right ventricular contraction and delayed closure of tricuspid leaflets.

    • Soft systolic ejection murmur audible in the pulmonic area.

    • Wide, fixed splitting of the second heart sound ($S_2$) due to reduced respiratory variation; fixed split $S_2$ occurs when pulmonary artery pressure is normal and pulmonary vascular resistance is low.

    • Mid-systolic murmur at the lower left sternal border (LSB) secondary to increased blood flow across the tricuspid valve.

    • Mitral valve regurgitation may be present in patients with an ostium primum defect associated with a cleft mitral valve.

• Ventricular Septal Defect (VSD):

  • Pathophysiology: An opening in the interventricular septum resulting in left-to-right blood shunting.

  • Clinical Manifestations:

    • Symptoms correlate with defect size and shunt degree.

    • Small VSDs: Asymptomatic; routine examination reveals a cardiac murmur.

    • Moderate VSDs: Excessive sweating during feedings; fatigue during feedings due to increased cardiac output demands; growth failure/lack of adequate growth from elevated metabolic and caloric needs.

    • Moderate-to-Large VSDs: Recurrent respiratory infections; congestive heart failure; tachypnea during exertion/exercise (not present at rest).

• Patent Ductus Arteriosus (PDA):

  • Pathophysiology: Failure of the fetal ductus arteriosus (connecting aorta to pulmonary artery) to close postnatally.

  • Clinical Manifestations:

    • Heart failure manifestations depend on defect size and shunt volume.

    • Characteristic harsh, continuous machine-like murmur.

    • Widening pulse pressure (increased numerical difference between systolic and diastolic blood pressures).

    • Bounding peripheral pulses.

    • Enlarged heart (cardiomegaly).

Decreased Pulmonary Blood Flow Lesions: Tetralogy of Fallot

• Anatomic Features of Tetralogy of Fallot:

  1. Pulmonic stenosis

  2. Overriding aorta

  3. Ventricular septal defect (VSD)

  4. Right ventricular hypertrophy

• Clinical Manifestations:

  • Hypoxia and systemic cyanosis.

  • Systolic murmur audible in the pulmonic area, accompanied by a palpable thrill at the pulmonic area.

  • Polycythemia (secondary to chronic hypoxemia).

  • Hypoxic episodes (hypercyanotic or "Tet" spells).

  • Metabolic acidosis.

  • Poor physical growth.

  • Digital clubbing of fingers.

  • Exercise intolerance.

• Therapeutic Management of Hypercyanotic Episodes ("Tet" Spells):

  • Positioning: Place the infant in the knee-chest position immediately to increase systemic vascular resistance.

  • Calming: Maintain a calm environment to reduce systemic metabolic demands.

  • Oxygenation: Administer supplemental oxygen.

  • Pharmacotherapy: Administer intravenous (IV) morphine and propranolol.

  • Critical Warning: Continually monitor for metabolic acidosis and prolonged unconsciousness.

Obstructive Lesions: Coarctation of the Aorta

• Pathophysiology: Localized narrowing/stenosis of the aorta near the site of the ductus arteriosus, obstructing systemic blood outflow from the left ventricle.

• Clinical Manifestations:

  • May remain completely asymptomatic.

  • Presence of a heart murmur.

  • Chronic systemic hypertension ($HTN$).

  • Headache and fatigue.

  • Differential cyanosis.

  • Absent or markedly decreased femoral pulses; distinct disparity between femoral and carotid pulse strength.

  • Significantly higher blood pressure ($BP$) and pulse force in upper extremities compared to lower extremities.

  • Poor perfusion in lower body: delayed capillary refill, pale/poor skin color, decreased urine output.

  • Signs of congestive heart failure: Dyspnea, cough, fatigue, peripheral edema.

• Lifespan Considerations for Coarctation of the Aorta:

  • Infants: May present as asymptomatic, or with absent femoral pulses, delayed capillary refill, feeding intolerance/problems, decreased responsiveness, rapid breathing, grunting, and nasal flaring.

  • Children and Adolescents: Easy fatigability, exertion-induced shortness of breath ($SOB$), extremity swelling.

  • Pregnancy: Exacerbation of symptoms driven by increased circulating blood volume, elevated blood pressure, and heightened myocardial workload; significant maternal anxiety.

  • Adults: Cyanosis, $SOB$, persistent headache, lower limb claudication, high risk of severe complications including dysrhythmias, stroke, heart failure ($HF$), pulmonary hypertension ($HTN$), and heart valve pathology.

Mixed Disorders: Hypoplastic Left Heart Syndrome (HLHS)

• Anatomic Features:

  • Severe hypoplasia/underdevelopment of the left ventricle and ascending aorta.

  • Presence of an Atrial Septal Defect (ASD) or patent foramen ovale.

  • Presence of a Patent Ductus Arteriosus (PDA) providing obligatory systemic flow.

• Etiology and Risk Factors:

  • Higher prevalence in males.

  • Familial genetic inheritance patterns exist, though precise origins remain unclear.

  • Associated with genetic and chromosomal conditions:

    1. Turner Syndrome

    2. Trisomy 13, Trisomy 18, and Trisomy 21

    3. Noonan Syndrome

• Prognosis and Lifespan Data:

  • Approximately $\\frac{1}{3}$ of live-born infants with HLHS die prior to undergoing initial surgical intervention.

  • Patients are restricted from competitive sports and high-demand physical exertion, but can otherwise maintain a satisfactory quality of life.

  • Approximately $\\frac{1}{3}$ of HLHS patients die by age $25$ years due to right ventricular failure.

  • Definitive long-term therapy is cardiac transplantation.

• Pre-Operative Management:

  • Alprostadil (Prostaglandin $E_1$ / PGE1): Continuous IV infusion to maintain ductal patency and systemic vasodilation.

  • Mechanical Ventilation: Support airway and gas exchange.

  • Oxygen Restriction: Avoid supplemental oxygen ($O_2$). Oxygen acts as a potent pulmonary vasodilator, increasing pulmonary blood flow at the expense of systemic perfusion. This causes systemic hypoperfusion and places excessive workload on the already stressed single right ventricle.

  • Supportive Care: Administration of IV fluids and placement of a feeding tube.

  • Interventional Procedure: Palliative Atrial Septostomy to construct a large interatrial opening, maximizing mixing of systemic and pulmonary venous return.

• Three-Stage Surgical Reconstruction Strategy:

  1. Norwood Procedure:

     • Performed within the first $2\\,\\text{weeks}$ of life.

     • Constructs a new systemic aorta utilizing the right ventricle.

     • Places a systemic-to-pulmonary shunt (from aorta or right ventricle to pulmonary arteries) to ensure pulmonary blood flow.

     • Infant remains cyanotic post-operatively due to mandatory blood mixing ($O_2$ saturation remains lower than normal).

  2. Bi-directional Glenn Procedure:

     • Performed at $4\\text{--}6\\,\\text{months}$ of age.

     • Directly connects the superior vena cava ($SVC$) to the right pulmonary artery.

     • Diverts oxygen-poor blood from upper body directly into pulmonary circulation, significantly reducing right ventricular volume overload.

  3. Fontan Procedure:

     • Performed between $18\\,\\text{months}$ and $4\\,\\text{years}$ of age.

     • Connects the inferior vena cava ($IVC$) directly to the pulmonary arteries.

     • Directs all systemic venous return from lower body into lungs without passing through the heart.

     • Completely eliminates blood mixing; systemic cyanosis resolves and skin color normalizes.

Physical Examination and Murmur Evaluation

• General Assessment Findings in Cardiac Defects:

  • Cyanosis

  • Peripheral or central edema

  • Digital clubbing

  • Fever

  • Intercostal/subcostal retractions

  • Prominence or bulging of precordial chest wall

  • Visible, engorged, or abnormal arterial/venous pulsations

  • Abdominal distention (hepatomegaly/splenomegaly)

• Auscultatory Characteristics of Cardiac Murmurs:

  • Anatomic Location: Point of maximal intensity on chest wall.

  • Timing and Duration: Position in cardiac cycle (systolic, diastolic, continuous).

  • Intensity Grading Scale:

    • Grade I: Soft, faint, and difficult to hear.

    • Grade II: Soft, but easily audible.

    • Grade III: Loud murmur without an associated palpable thrill.

    • Grade IV: Loud murmur accompanied by a palpable precordial thrill.

    • Grade V: Very loud murmur audible with stethoscope placed lightly on chest wall, accompanied by a thrill.

    • Grade VI: Extremely loud murmur, audible with stethoscope off chest wall or with the naked ear.

  • Auscultatory Quality: Described as harsh, musical, or rough; classified by high, medium, or low pitch.

  • Positional Variation: Alterations in sound quality or intensity during dynamic positioning (sitting, lying supine, standing).

Comprehensive Nursing Process and Clinical Goals

• Core Goals of Pediatric Cardiac Nursing Care:

  • Improving Oxygenation: Optimizing gas exchange and systemic tissue oxygen delivery.

  • Promoting Adequate Nutrition: Meeting elevated metabolic demands via high-calorie density feedings and enteral support.

  • Fostering Coping Strategies: Supporting patient and family through severe psychological stress and chronic disease burden.

  • Postoperative Care: Rigorous monitoring of hemodynamic parameters, fluid balance, surgical sites, and organ perfusion post-reconstruction.

  • Infection Prevention: Strict aseptic protocols and prophylactic strategies against endocarditis and systemic infections.

  • Education: Providing extensive age-appropriate guidance to patient and caregivers regarding disease progression, surgical stages, emergency signs, and home management.

  • Complication Surveillance: Early identification and management of heart failure, dysrhythmias, metabolic acidosis, hypoxemia, and developmental delays.